Organization | Larix A/S

Larix A/S Report issue

For profit Phase 2 Phase 3

Founded: Herlev Denmark (2001)

Organization Overview

First Clinical Trial

2014

NCT02280447

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2018

Timeline

NOW

Now

Alternative names

Larix A/S

Active Ingredients

Drugs in Phase 3 Trials (2)

ipv-al ssi (3 trials)

Drugs in Phase 2 Trials (3)

glepaglutide (1 trial)

poliovirus vaccine inactivated (2 trials)

potassium alum (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Poliomyelitis (Phase 3)

Short Bowel Syndrome (Phase 2)

Overview

Highest Phase: Phase 3
# of Trials: 6
# of Trial APIs: 5